Skip to main content

Call for papers - Stem cell models in psychiatry

Guest Editors:
Biju Viswanath, MD, PhD, National Institute of Mental Health and Neurosciences, India
Zhexing Wen, PhD, Emory University, USA


Submission Status: Open   |   Submission Deadline: 25 July 2024
 

BMC Psychiatry welcomes submissions for the Collection Stem cell models in psychiatry.

The use of stem cells to treat psychiatric disorders is a new concept with a strong potential for practical use. The proliferation and differentiation capacity of human stem cells allows scientists to use them as more clinically relevant models to study the causes, pathologies, and mechanisms of certain diseases, making it a potentially preferable option to medications and diagnostic methods that are currently in use. For example, it could diminish the number of side-effects seen within so many medications for psychiatric disorders. Additionally, the application of stem cell treatment has the potential to assist in cases involving patients who do not regularly take prescribed medication.

This Collection is interested in all original research related to stem cell models and their use in psychiatry.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing.

Meet the Guest Editors

Back to top

Biju Viswanath, MD, PhD, National Institute of Mental Health and Neurosciences, India

Dr Biju Viswanath is an Additional Professor of Psychiatry at the National Institute of Mental Health and Neurosciences. His primary area of research includes the molecular basis of etiology and treatment response in neuropsychiatric disorders. He is specifically interested in psychiatric genetics and cellular models.

Dr Viswanath is a key investigator in the Accelerator Program for Discovery in Brain Disorders using Stem Cells. He also established the Indian Consortium on Mental Illness and Genetics in the Clinic, a network of psychiatrists and scientists based in India within the field of psychiatric genetics. He also serves as an Editorial Board Member for BMC Psychiatry.

Zhexing Wen, PhD, Emory University, USA

Dr Zhexing Wen is an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Cell biology, and Neurology at Emory University School of Medicine. His current research examines the use of human induced pluripotent stem cell models to understand the molecular mechanisms underlying neuropsychiatric and neurological disorders, and translate such knowledge into therapeutic targets for developing novel treatments.

About the Collection

BMC Psychiatry welcomes submissions for the Collection Stem cell models in psychiatry.

The use of stem cells to treat psychiatric disorders is a new concept with a strong potential for practical use. The proliferation and differentiation capacity of human stem cells allows scientists to use them as more clinically relevant models to study the causes, pathologies, and mechanisms of certain diseases, making it a potentially preferable option to medications and diagnostic methods that are currently in use. For example, it could diminish the number of side-effects seen within so many medications for psychiatric disorders. Additionally, the application of stem cell treatment has the potential to assist in cases involving patients who do not regularly take prescribed medication.

This Collection is interested in all original research related to stem cell models and their use in psychiatry.

Image credit: Elie Maksoud / NatureJobs Scientist at Work competition

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Stem cell models in psychiatry" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.